Nordic collaborative study of the BARD1 Cys557Ser allele in 3956 patients with cancer: enrichment in familial BRCA1/BRCA2 mutation‐negative breast cancer but not in other malignancies

BACKGROUND: BARD1 was originally identified as a BRCA1‐interacting protein but has also been described in tumour‐suppressive functions independent of BRCA1. Several studies have indicated that the BARD1 gene is a potential target for germline changes predisposing to breast and ovarian cancer. The C‐...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Karppinen, S‐M, Barkardottir, R B, Backenhorn, K, Sydenham, T, Syrjäkoski, K, Schleutker, J, Ikonen, T, Pylkäs, K, Rapakko, K, Erkko, H, Johannesdottir, G, Gerdes, A‐M, Thomassen, M, Agnarsson, B A, Grip, M, Kallioniemi, A, Kere, J, Aaltonen, L A, Arason, A, Møller, P, Kruse, T A, Borg, Å, Winqvist, R
التنسيق: Artigo
اللغة:Inglês
منشور في: BMJ Group 2006
الموضوعات:
Original Article
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC2563183/
https://ncbi.nlm.nih.gov/pubmed/16825437
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jmg.2006.041731
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة